Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 5Myeloid 5Plasma cell 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma 725Lymphoma, Non-Hodgkin 657Precursor Cell Lymphoblastic Leukemia-Lymphoma 583Leukemia, Lymphocytic, Chronic, B-Cell 555Lymphoma, Large B-Cell, Diffuse 440Lymphoma, Follicular 418Lymphoma, Mantle-Cell 345Burkitt Lymphoma 306Leukemia 303Leukemia, Myeloid, Acute 297Hodgkin Disease 293Lymphoma, B-Cell 280Lymphoma, B-Cell, Marginal Zone 267Recurrence 246Multiple Myeloma 205Neoplasms 199Lymphoma, T-Cell, Cutaneous 171Myelodysplastic Syndromes 170Lymphoma, Large-Cell, Immunoblastic 160Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 159Waldenstrom Macroglobulinemia 146Lymphoma, Large-Cell, Anaplastic 142Mycosis Fungoides 132Sezary Syndrome 119Immunoblastic Lymphadenopathy 108Blast Crisis 92Hematologic Neoplasms 91Lymphoma, T-Cell, Peripheral 86Leukemia, Myelogenous, Chronic, BCR-ABL Positive 86Lymphoma, T-Cell 82

Interventions

fludarabine 1Melphalan 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Preleukemia × Lymphoid × Clear all
NCT00943293 2014-03-17

Minor Histocompatibility Vaccination After Allogeneic Stem Cell Transplantation for Advanced Hematologic Malignancies

University of Chicago

Phase 1 Terminated
1 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Lymphoma, Myeloproliferative Disorders, Preleukemia, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡